BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pearce L, Davidson SM, Yellon DM. Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Res Cardiol 2021;116:12. [PMID: 33629195 DOI: 10.1007/s00395-021-00852-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang H, Gong W, Wang X, He W, Hou Y, Hu J. Self-Assembly of Naturally Small Molecules into Supramolecular Fibrillar Networks for Wound Healing. Adv Healthc Mater 2022;:e2102476. [PMID: 35306757 DOI: 10.1002/adhm.202102476] [Reference Citation Analysis]
2 Penna C, Comità S, Tullio F, Alloatti G, Pagliaro P. Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106995] [Reference Citation Analysis]
3 Guo W, Ren C, Zhang B, Zhao W, Gao Y, Yu W, Ji X. Chronic Limb Remote Ischemic Conditioning may have an Antihypertensive Effect in Patients with Hypertension. Aging Dis 2021;12:2069-79. [PMID: 34881086 DOI: 10.14336/AD.2021.0604] [Reference Citation Analysis]
4 Abbasi-Habashi S, Jickling GC, Winship IR. Immune Modulation as a Key Mechanism for the Protective Effects of Remote Ischemic Conditioning After Stroke. Front Neurol 2021;12:746486. [PMID: 34956045 DOI: 10.3389/fneur.2021.746486] [Reference Citation Analysis]
5 Davidson SM, Lukhna K, Gorog DA, Salama AD, Castillo AR, Giesz S, Golforoush P, Kalkhoran SB, Lecour S, Imamdin A, do Carmo HRP, Bovi TG, Perroud MW Jr, Ntsekhe M, Sposito AC, Yellon DM. RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19. Cardiovasc Drugs Ther 2021. [PMID: 34169381 DOI: 10.1007/s10557-021-07221-y] [Reference Citation Analysis]
6 Peng Y, Wang L, Zhao X, Lai S, He X, Fan Q, He H, He M. Puerarin attenuates lipopolysaccharide-induced myocardial injury via the 14-3-3γ/PKCε pathway activating adaptive autophagy. International Immunopharmacology 2022;108:108905. [DOI: 10.1016/j.intimp.2022.108905] [Reference Citation Analysis]
7 Zhang H, Liu Y, Cao X, Wang W, Cui X, Yang X, Wang Y, Shi J. Nrf2 Promotes Inflammation in Early Myocardial Ischemia-Reperfusion via Recruitment and Activation of Macrophages. Front Immunol 2021;12:763760. [DOI: 10.3389/fimmu.2021.763760] [Reference Citation Analysis]
8 Xiao L, Gu Y, Ren G, Chen L, Liu L, Wang X, Gao L. miRNA-146a Mimic Inhibits NOX4/P38 Signalling to Ameliorate Mouse Myocardial Ischaemia Reperfusion (I/R) Injury. Oxid Med Cell Longev 2021;2021:6366254. [PMID: 34367463 DOI: 10.1155/2021/6366254] [Reference Citation Analysis]
9 Donato M, Bin EP, D Annunzio V, Gelpi RJ. Myocardial remote ischemic preconditioning: from cell biology to clinical application. Mol Cell Biochem 2021;476:3857-67. [PMID: 34125317 DOI: 10.1007/s11010-021-04192-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Yang W, Lin J, Zhou J, Zheng Y, Jiang S, He S, Li D. Innate Lymphoid Cells and Myocardial Infarction. Front Immunol 2021;12:758272. [PMID: 34867998 DOI: 10.3389/fimmu.2021.758272] [Reference Citation Analysis]
11 Li Z, Chen X, Tao J, Shi A, Zhang J, Yu P. Exosomes Regulate NLRP3 Inflammasome in Diseases. Front Cell Dev Biol 2021;9:802509. [PMID: 35047512 DOI: 10.3389/fcell.2021.802509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bönner F, Gastl M, Nienhaus F, Rothe M, Jahn A, Pfeiler S, Gross U, Schultheiss HP, Ibanez B, Kozerke S, Szendroedi J, Roden M, Westenfeld R, Schrader J, Flögel U, Heusch G, Kelm M. Regional analysis of inflammation and contractile function in reperfused acute myocardial infarction by in vivo 19F cardiovascular magnetic resonance in pigs. Basic Res Cardiol 2022;117:21. [PMID: 35389088 DOI: 10.1007/s00395-022-00928-5] [Reference Citation Analysis]
13 Qu Y, Zhang P, He QY, Sun YY, Wang MQ, Liu J, Zhang PD, Yang Y, Guo ZN. The Impact of Serial Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation and Brain Injury Related Biomarkers. Front Physiol 2022;13:835173. [PMID: 35273521 DOI: 10.3389/fphys.2022.835173] [Reference Citation Analysis]
14 Cui Y, Yu H, Bu Z, Wen L, Yan L, Feng J. Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics. Front Mol Neurosci 2022;15:894298. [DOI: 10.3389/fnmol.2022.894298] [Reference Citation Analysis]
15 Zhang C, Wang X, Wang C, He C, Ma Q, Li J, Wang W, Xu YT, Wang T. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation. Front Pharmacol 2021;12:790072. [PMID: 35002723 DOI: 10.3389/fphar.2021.790072] [Reference Citation Analysis]
16 Zhang B, Zhao W, Ma H, Zhang Y, Che R, Bian T, Yan H, Xu J, Wang L, Yu W, Liu J, Song H, Duan J, Chang H, Ma Q, Zhang Q, Ji X. Remote Ischemic Conditioning in the Prevention for Stroke-Associated Pneumonia: A Pilot Randomized Controlled Trial. Front Neurol 2022;12:723342. [DOI: 10.3389/fneur.2021.723342] [Reference Citation Analysis]